• About Us/
  • News/
  • Investor Area/
  • Contact/
  • Home/

  • Life Sciences
  • Technology

  • Advent Venture Partners
  • Home

Advent Venture Partners is one of Europe’s most successful growth
and venture capital investors in market-leading tech and life sciences businesses


  • Celgene to Acquire Avila Therapeutics

    Oral Btk inhibitor AVL-292 offers promising potential for treatment of B-cell diseases


  • Amgen to Acquire Micromet

    Acquisition Includes a Novel Cancer Treatment in Clinical Trials for Hematologic Malignancies


  • farfetch.com raises $18m to accelerate growth and expands further into US, Brazil and Asia


  • eBay Inc. to Acquire Zong for $240m

    Zong strengthens PayPal's leadership position in mobile payments and digital goods


  • Follow Advent
  • Tech Blog
  • Twitter
  • LinkedIn

  • Legal and Regulatory Matters

©2012 Advent Venture Partners